UK study explores lung cancer in people who have never smoked
Researchers in the UK are working on a study called OLIVE to learn more about lung cancer in people who have never smoked.
The study is important because lung cancer is still often linked too strongly with smoking. That can make it harder for people who have never smoked to recognise possible symptoms, and harder for others to think lung cancer could be the cause.
Better evidence could help improve awareness, diagnosis and care.
What is the OLIVE study?
OLIVE is a UK study looking at lung cancer in people who have never smoked.
It is led by Professor Neal Navani and supported by the NIHR Biomedical Research Centre, University College London (UCL) and the Ruth Strauss Foundation.
Researchers are using information from GP and hospital records to build a clearer picture of who is affected, how diagnosis happens, and what outcomes look like over time.
The study also aims to create a stronger evidence base for future research in this area.
Why does this matter?
Anyone with lungs can get lung cancer.
But people who have never smoked can face extra barriers. Lung cancer may not be considered straight away, because of the outdated idea that it is only a disease linked to smoking.
That can lead to delays in diagnosis.
Research like OLIVE matters because it could help:
improve understanding of lung cancer in people who have never smoked
support earlier recognition of symptoms
strengthen the case for better awareness and education
build evidence for future policy and advocacy work in the UK
What happens next?
OLIVE is an ongoing study, so it has not yet produced its main findings.
Recruitment is open until September 2029, and over time the study should help researchers and healthcare professionals understand more about this under-recognised area of lung cancer.
For people affected by lung cancer, that matters. Better understanding is one of the first steps towards better care.
Suggested link text
Read more about the OLIVE study on the Cancer Research UK website.